procarbazine has been researched along with Kahler Disease in 50 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-four patients with progressive symptomatic multiple myeloma were treated with a protocol combining cyclophosphamide (10 mg/kg weekly), procarbazine (2 mg/kg daily), prednisolone (20 mg daily), and either BCNU (1 mg/kg weekly) (BCPP protocol) or MCNU (0." | 7.67 | [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy]. ( Ito, T; Komatsu, M; Saito, Y; Takahashi, H; Uzuka, Y, 1989) |
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 7.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| "To compare VMCP, a multidrug combination chemotherapy comprising vincristine (VCR), melphalan (MPH), cyclophosphamide (CPM) and prednisolone (PSL), with MMPP comprising MPH, ranimustine (MCNU), procarbazine, and PSL as induction, to elucidate the value of alternating combination chemotherapy, and to search for an appropriate maintenance therapy in multiple myeloma." | 5.08 | A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma. ( Hirabayashi, N; Hotta, T; Ichikawa, A; Kamiya, O; Kato, R; Kato, Y; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Naito, K; Nishiwaki, H; Nitta, M; Saito, H; Shibata, T; Shimizu, K; Takeyama, H; Tanaka, M; Utsumi, M, 1997) |
| "The effects of various regimens of melphalan combination chemotherapy were evaluated in 508 patients with multiple myeloma." | 5.04 | Remission maintenance therapy for multiple myeloma. ( , 1975) |
| "A newly designed combination chemotherapy for multiple myeloma, MMCP [ranimustine (MCNU), melphalan (MPH), cyclophosphamide (CPM) and prednisolone (PSL)], was analyzed and compared with the results of our previous randomized trial of VMCP [vincristine, MPH, CPM and PSL] and MMPP [MCNU, MPH, procarbazine and PSL]." | 3.71 | Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma. ( Ichikawa, A; Kamiya, O; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Nitta, M; Saito, H; Shimizu, K; Takeyama, H; Wakita, A; Yamao, H, 2002) |
| "Seventy patients with progressive multiple myeloma received combination chemotherapy with cyclophosphamide and prednisolone (CP), BCNU, cyclophosphamide, procarbazine and prednisolone (BCPP), and MCNU, cyclophosphamide, melphalan and prednisolone (MCMP) as first line treatment." | 3.68 | [Combination chemotherapy of multiple myeloma]. ( Ito, T; Saito, Y; Uzuka, Y, 1990) |
| "Forty-four patients with progressive symptomatic multiple myeloma were treated with a protocol combining cyclophosphamide (10 mg/kg weekly), procarbazine (2 mg/kg daily), prednisolone (20 mg daily), and either BCNU (1 mg/kg weekly) (BCPP protocol) or MCNU (0." | 3.67 | [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy]. ( Ito, T; Komatsu, M; Saito, Y; Takahashi, H; Uzuka, Y, 1989) |
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 3.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| "We report two patients who developed visual hallucinations during treatment with vincristine." | 1.29 | Visual hallucinations following treatment with vincristine. ( Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK, 1994) |
| "One hundred and fifty-six patients with multiple myeloma were treated over a period of 12 years at St." | 1.29 | Myeloma during a decade: clinical experience in a single centre. ( Carter, M; Clark, PI; Ganjoo, RK; Gregory, W; Johnson, PW; Lim, JM; Love, SB; Mahmoud, MM; Malpas, JS; Williams, AH, 1995) |
| " Because of rapid progression of the amyloidosis and further infections, cytotoxic drug therapy was stopped, corticosteroid dosage was decreased, and supplementary immunoglobulin therapy was instituted." | 1.25 | Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy. ( Dawkins, RL; Zilko, PJ, 1975) |
| "3 cases of multiple myeloma are still living 44 months after the onset of symptoms." | 1.25 | Treatment of multiple myeloma and macroglobulinemai Waldenström: A long-term follow-up study. ( Mikami, M; Oikawa, K; Onodera, S; Otaki, M; Sato, I, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (76.00) | 18.7374 |
| 1990's | 7 (14.00) | 18.2507 |
| 2000's | 4 (8.00) | 29.6817 |
| 2010's | 1 (2.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rancea, M | 1 |
| Will, A | 1 |
| Borchmann, P | 1 |
| Monsef, I | 1 |
| Engert, A | 2 |
| Skoetz, N | 1 |
| Strobel, ES | 1 |
| Bauchmüller, K | 1 |
| Schmitt-Gräff, A | 1 |
| Engelhardt, M | 1 |
| Kober, T | 1 |
| Hülsewede, H | 1 |
| Bohlius, J | 1 |
| Freireich, EJ | 1 |
| Keating, M | 1 |
| Cabanillas, F | 1 |
| Barlogie, B | 1 |
| Lazarus, HM | 1 |
| Adelstein, DJ | 1 |
| Herzig, RH | 1 |
| Smith, MC | 1 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Rosner, F | 1 |
| Santoro, A | 1 |
| Schieppati, G | 1 |
| Franchi, F | 1 |
| Valagussa, P | 1 |
| Monfardini, S | 1 |
| Furukawa, K | 1 |
| Fujiwara, Y | 1 |
| Nakaide, Y | 1 |
| Tanaka, M | 3 |
| Hirota, Y | 1 |
| Tribalto, M | 1 |
| Arcese, W | 1 |
| Colombo, R | 1 |
| Pastore, S | 1 |
| Franchii, A | 1 |
| Ghosh, K | 1 |
| Sivakumaran, M | 1 |
| Murphy, P | 1 |
| Chapman, CS | 1 |
| Wood, JK | 1 |
| Malpas, JS | 2 |
| Ganjoo, RK | 1 |
| Johnson, PW | 1 |
| Mahmoud, MM | 1 |
| Williams, AH | 1 |
| Carter, M | 1 |
| Gregory, W | 1 |
| Lim, JM | 1 |
| Love, SB | 1 |
| Clark, PI | 1 |
| Kato, Y | 2 |
| Takeda, H | 1 |
| Mihara, H | 1 |
| Kobayashi, H | 1 |
| Kamijima, S | 1 |
| Kuwahara, M | 1 |
| Oguri, T | 1 |
| Nagasaka, T | 1 |
| Nagura, E | 2 |
| Ichikawa, A | 2 |
| Kamiya, O | 3 |
| Kato, R | 1 |
| Utsumi, M | 1 |
| Takeyama, H | 2 |
| Shimizu, K | 2 |
| Kobayashi, M | 2 |
| Naito, K | 1 |
| Nishiwaki, H | 1 |
| Mizuno, H | 2 |
| Hirabayashi, N | 1 |
| Nitta, M | 2 |
| Shibata, T | 1 |
| Hotta, T | 1 |
| Kawashima, K | 2 |
| Saito, H | 2 |
| Fermand, JP | 1 |
| Ravaud, P | 1 |
| Chevret, S | 1 |
| Divine, M | 1 |
| Leblond, V | 1 |
| Belanger, C | 1 |
| Macro, M | 1 |
| Pertuiset, E | 1 |
| Dreyfus, F | 1 |
| Mariette, X | 1 |
| Boccacio, C | 1 |
| Brouet, JC | 1 |
| Buijt, I | 1 |
| Ossenkoppele, GJ | 1 |
| Uyl-de Groot, CA | 1 |
| Huijgens, PC | 1 |
| Colombi, M | 1 |
| Guffanti, A | 1 |
| Alietti, A | 1 |
| Latargia, ML | 1 |
| Vener, C | 1 |
| Maiolo, AT | 1 |
| Baldini, L | 1 |
| Yamao, H | 1 |
| Wakita, A | 1 |
| Zilko, PJ | 1 |
| Dawkins, RL | 1 |
| Foa, J | 1 |
| Carcassonne, Y | 1 |
| Sieber, SM | 1 |
| Sakalová, A | 1 |
| Drobná, V | 1 |
| Hrubisková, D | 1 |
| Tortarolo, M | 1 |
| Cantore, N | 1 |
| Russolillo, S | 1 |
| Castaldo, C | 1 |
| Buonanno, G | 1 |
| Lennan, RM | 1 |
| Taylor, HR | 1 |
| Andreeva, NE | 1 |
| Antipova, LG | 1 |
| Bergsagel, DE | 2 |
| Onodera, S | 1 |
| Otaki, M | 1 |
| Oikawa, K | 1 |
| Mikami, M | 1 |
| Sato, I | 1 |
| Wands, JR | 1 |
| Chura, CM | 1 |
| Roll, FJ | 1 |
| Maddrey, WC | 1 |
| Jacobs, P | 2 |
| Dubovsky, D | 2 |
| Uzuka, Y | 2 |
| Saito, Y | 2 |
| Ito, T | 2 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Hoshino, A | 1 |
| Ohara, K | 1 |
| Nagata, K | 1 |
| Ono, Y | 1 |
| Saito, M | 1 |
| Itou, T | 1 |
| Yamamoto, K | 1 |
| Takahashi, H | 1 |
| Komatsu, M | 1 |
| Tsykalov, VA | 1 |
| Zhuravlev, VS | 1 |
| Mokeeva, RA | 1 |
| Adachi, T | 1 |
| Sezaki, T | 1 |
| Hoshijima, T | 1 |
| Izumi, K | 1 |
| Tsubota, T | 1 |
| Asano, K | 1 |
| Takahashi, I | 1 |
| Kimura, I | 1 |
| Murakami, M | 1 |
| Lira, P | 1 |
| Walker, B | 1 |
| Grebe, G | 1 |
| Wilmanns, W | 1 |
| Binsack, T | 1 |
| Sauer, H | 1 |
| Cawley, JC | 1 |
| Goldstone, AH | 1 |
| Arno, J | 1 |
| Rees, JH | 1 |
| Grant, A | 1 |
| Coleman, M | 1 |
| Silver, RT | 1 |
| Sonntag, R | 1 |
| Favre, E | 1 |
| Martz, G | 1 |
| Brodskaia, NA | 1 |
| Spivack, SD | 1 |
| Rodriguez, LH | 1 |
| Finkelstein, JB | 1 |
| Shullenberger, CC | 1 |
| Alexanian, R | 2 |
| Bonnet, J | 1 |
| Gehan, E | 1 |
| Haut, A | 1 |
| Hewlett, J | 1 |
| Lane, M | 1 |
| Monto, R | 1 |
| Wilson, H | 1 |
| Yium, J | 1 |
| Martinez-Maldonado, M | 1 |
| Eknoyan, G | 1 |
| Suki, WN | 1 |
| Moon, JH | 1 |
| Edmonson, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| (PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
| A Phase 2, Open-label, Prospective, Multicenter Study to Evaluate the Efficacy of Intravenous Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation[NCT01923935] | Phase 2 | 105 participants (Anticipated) | Interventional | 2013-01-31 | Recruiting | ||
| Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01453088)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 27 |
| Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 13 |
| Auto Transplant High Dose Melphalan+Bortezomib | 11 |
13 reviews available for procarbazine and Kahler Disease
| Article | Year |
|---|---|
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1984 |
[Chemotherapy of multiple myeloma. Review of the recent trials].
Topics: Antineoplastic Agents; Azathioprine; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combi | 1981 |
[Treatment of Kahler's disease].
Topics: Bone Neoplasms; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Multiple | 1976 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
[Recent progress in chemotherapy of multiple myeloma].
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; | 1978 |
[Treatment of multiple myeloma (generalized plasmacytoma)].
Topics: Anabolic Agents; Antineoplastic Agents; Ethylnitrosourea; Glucocorticoids; Humans; Kidney Failure, C | 1975 |
The treatment of plasma cell myeloma.
Topics: Animals; Carmustine; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Me | 1976 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
The chemotherapy of plasma cell myeloma and related disorders.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Multiple Myel | 1974 |
Plasma cell myeloma. An interpretive review.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Carmustine; Cell Division; Cyclophosphamide; Drug Re | 1972 |
[Natulan (experimental and clinical data on its antitumor effect)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzoates; Bronchial Neoplasms; Hodgkin Diseas | 1972 |
Drugs 5 years later: procarbazine.
Topics: Animals; Bone Neoplasms; Carcinogens; Carcinoma; Drug Evaluation; Hodgkin Disease; Humans; Lung Neop | 1974 |
6 trials available for procarbazine and Kahler Disease
| Article | Year |
|---|---|
A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Melphalan; Mi | 1997 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1998 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cau | 2000 |
Remission maintenance therapy for multiple myeloma.
Topics: Bone Neoplasms; Carmustine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; | 1975 |
[Therapeutic experiences in multiple myeloma].
Topics: Aniline Compounds; Antineoplastic Agents; Blood Sedimentation; Carmustine; Clinical Trials as Topic; | 1972 |
Combination chemotherapy for multiple myeloma.
Topics: Antineoplastic Agents; Benzoates; Drug Combinations; Evaluation Studies as Topic; Humans; Immunoglob | 1972 |
31 other studies available for procarbazine and Kahler Disease
| Article | Year |
|---|---|
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality | 2005 |
Long-term survival of patients with multiple myeloma and acute renal failure at presentation.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cy | 1983 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Cancer and secondary leukemia.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Child; Child, Preschool; Female; | 1983 |
Clinical staging and therapeutic results in multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Male; Melp | 1983 |
[Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; H | 1980 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin | 1994 |
Myeloma during a decade: clinical experience in a single centre.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla | 1995 |
Oral low-dose etoposide therapy for refractory multiple myeloma with extramedullary involvement.
Topics: Administration, Oral; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; E | 1995 |
Costs of intensive treatment and follow-up of patients with multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Costs and Co | 1998 |
Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; M | 2002 |
Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy.
Topics: Agammaglobulinemia; Amyloidosis; Bence Jones Protein; Dermatomyositis; gamma-Globulins; Humans; Immu | 1975 |
[Various immunologic indicators of cytostatic therapy in patients with malignant lymphoproliferative processes].
Topics: Cyclophosphamide; Humans; Immunologic Techniques; Leukemia, Lymphoid; Lymphocytes; Multiple Myeloma; | 1977 |
Optic neuroretinitis in association with BCNU and procarbazine therapy.
Topics: Carmustine; Drug Therapy, Combination; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple My | 1978 |
Treatment of multiple myeloma and macroglobulinemai Waldenström: A long-term follow-up study.
Topics: Adult; Aged; Cyclophosphamide; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Mult | 1975 |
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
Topics: Adolescent; Adult; Antibodies, Viral; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubi | 1975 |
Letter: Treatment of myeloma.
Topics: Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Procarbazine; Vincristin | 1975 |
[Combination chemotherapy of multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclopho | 1990 |
[Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evalua | 1989 |
[Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy].
Topics: Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 1989 |
[Polychemotherapy of multiple myeloma using pafencil (COPPaf protocol)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; | 1989 |
[Clinical study on chemotherapy for multiple myeloma: Part IV: Prognostic factors related to long survival].
Topics: Aclarubicin; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma | 1988 |
[Multiple myeloma: therapeutic response to 2 modalities of chemotherapy].
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 1986 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dac | 1985 |
Letter: Acute leukaemia and myeloma.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Melphalan; Multiple Myelo | 1974 |
Myeloma in a case of hodgkin's disease.
Topics: Aged; Hodgkin Disease; Humans; Male; Multiple Myeloma; Procarbazine; Time Factors; Vinca Alkaloids | 1974 |
Blood and neoplastic diseases. Myelomatosis.
Topics: Blood Viscosity; Bone Diseases; Cyclophosphamide; Fluorides; Humans; Hypercalcemia; Melphalan; Multi | 1974 |
Bone healing in multiple myeloma with melphalan chemotherapy.
Topics: Adult; Aged; Blood Urea Nitrogen; Bone Regeneration; Female; Humans; Male; Melphalan; Middle Aged; M | 1972 |
Peritoneal dialysis in the treatment of renal failure in multiple myeloma.
Topics: Coma; Cyclophosphamide; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Middle Aged; Multip | 1971 |
Procarbazine (NSC-77213) and multiple myeloma.
Topics: Antineoplastic Agents; Benzoates; Blood Platelets; Blood Urea Nitrogen; Bone Marrow Cells; Evaluatio | 1970 |